SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-059429
Filing Date
2020-11-19
Accepted
2020-11-19 16:53:33
Documents
2
Period of Report
2020-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1600
2 POA DOCUMENT poa.txt EX-24.3_946110 4102
  Complete submission text file 0001209191-20-059429.txt   7203
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIACELL, INC. 245 FIRST STREET CAMBRIDGE MA 02142
Business Address
Thistle Mary (Reporting) CIK: 0001317917 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33038 | Film No.: 201329389